BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 38313884)

  • 1. Liquid Biopsies for Monitoring Medulloblastoma: Circulating Tumor DNA as a Biomarker for Disease Progression and Treatment Response.
    Buccilli B; Rodriguez Molina MA; Redrovan Palomeque DP; Herrera Sabán CA; C Caliwag FM; Contreras Flores CJS; Abeysiriwardana CWJ; Diarte E; Arruarana VS; Calderon Martinez E
    Cureus; 2024 Jan; 16(1):e51712. PubMed ID: 38313884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.
    Liu APY; Smith KS; Kumar R; Paul L; Bihannic L; Lin T; Maass KK; Pajtler KW; Chintagumpala M; Su JM; Bouffet E; Fisher MJ; Gururangan S; Cohn R; Hassall T; Hansford JR; Klimo P; Boop FA; Stewart CF; Harreld JH; Merchant TE; Tatevossian RG; Neale G; Lear M; Klco JM; Orr BA; Ellison DW; Gilbertson RJ; Onar-Thomas A; Gajjar A; Robinson GW; Northcott PA
    Cancer Cell; 2021 Nov; 39(11):1519-1530.e4. PubMed ID: 34678152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unlocking the future of cancer diagnosis - promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer.
    Reina C; Šabanović B; Lazzari C; Gregorc V; Heeschen C
    Transl Res; 2024 Jun; 272():41-53. PubMed ID: 38838851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsies for the diagnosis and surveillance of primary pediatric central nervous system tumors: a review for practicing neurosurgeons.
    Bounajem MT; Karsy M; Jensen RL
    Neurosurg Focus; 2020 Jan; 48(1):E8. PubMed ID: 31896088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives.
    Peng Y; Mei W; Ma K; Zeng C
    Front Oncol; 2021; 11():763790. PubMed ID: 34868984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous Ultra-Sensitive Detection of Structural and Single Nucleotide Variants Using Multiplex Droplet Digital PCR in Liquid Biopsies from Children with Medulloblastoma.
    Arthur C; Jylhä C; de Ståhl TD; Shamikh A; Sandgren J; Rosenquist R; Nordenskjöld M; Harila A; Barbany G; Sandvik U; Tham E
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Applications of Liquid Biopsies in Pediatric Brain Tumors: A Systematic Literature Review.
    Greuter L; Frank N; Guzman R; Soleman J
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review.
    Van Paemel R; Vlug R; De Preter K; Van Roy N; Speleman F; Willems L; Lammens T; Laureys G; Schleiermacher G; Tytgat GAM; Astrahantseff K; Deubzer H; De Wilde B
    Eur J Pediatr; 2020 Feb; 179(2):191-202. PubMed ID: 31897843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy in CNS tumors: Current status & future perspectives.
    Husain N; Husain A; Mishra S; Srivastava P
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S111-S121. PubMed ID: 35562141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer.
    Shields MD; Chen K; Dutcher G; Patel I; Pellini B
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening.
    Kojic M; Maybury MK; Waddell N; Koufariotis LT; Addala V; Millar A; Wood S; Pearson JV; Hansford JR; Hassall T; Wainwright BJ
    Neuro Oncol; 2023 Aug; 25(8):1507-1517. PubMed ID: 36757207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Circulating Tumor DNA in Hematological Malignancy.
    Ogawa M; Yokoyama K; Imoto S; Tojo A
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33923024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.
    Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R
    Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma.
    Escudero L; Llort A; Arias A; Diaz-Navarro A; Martínez-Ricarte F; Rubio-Perez C; Mayor R; Caratù G; Martínez-Sáez E; Vázquez-Méndez É; Lesende-Rodríguez I; Hladun R; Gros L; Ramón Y Cajal S; Poca MA; Puente XS; Sahuquillo J; Gallego S; Seoane J
    Nat Commun; 2020 Oct; 11(1):5376. PubMed ID: 33110059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Role and Future Potential of CSF ctDNA for the Diagnosis and Clinical Management of Pediatric Central Nervous System Tumors.
    Miller AM; Karajannis MA
    J Natl Compr Canc Netw; 2022 Dec; 20(12):1363-1369. PubMed ID: 36509077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting liquid remnants of solid tumors treated with curative intent: Circulating tumor DNA as a biomarker of minimal residual disease (Review).
    Chen H; Zhou Q
    Oncol Rep; 2023 May; 49(5):. PubMed ID: 37052271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors.
    Yan W; Xu T; Zhu H; Yu J
    Onco Targets Ther; 2020; 13():719-731. PubMed ID: 32158224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ctDNA-Based Liquid Biopsy of Cerebrospinal Fluid in Brain Cancer.
    Escudero L; Martínez-Ricarte F; Seoane J
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33919036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma.
    Li J; Zhao S; Lee M; Yin Y; Li J; Zhou Y; Ballester LY; Esquenazi Y; Dashwood RH; Davies PJA; Parsons DW; Li XN; Huang Y; Sun D
    Sci Adv; 2020 Oct; 6(42):. PubMed ID: 33067228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.